IFAM
HAE icon

Institutional & Family Asset Management’s Haemonetics HAE Stock Holding History

Institutional & Family Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$745 Hold
9
– – ﹤0.01% 670
2024
Q1 		$768 Hold
9
– – ﹤0.01% 662
2023
Q4 		$770 Hold
9
– – ﹤0.01% 639
2023
Q3 		$806 Buy
9
+4
+80% +$357 ﹤0.01% 629
2023
Q2 		$426 Hold
5
– – ﹤0.01% 698
2023
Q1 		$414 Buy
+5
New +$405 ﹤0.01% 684
2020
Q2 		– Sell
-22
Closed -$2K – 868
2020
Q1 		$2K Hold
22
– – ﹤0.01% 647
2019
Q4 		$3K Hold
22
– – ﹤0.01% 661
2019
Q3 		$3K Buy
22
+5
+29% +$635 ﹤0.01% 630
2019
Q2 		$2K Hold
17
– – ﹤0.01% 715
2019
Q1 		$1K Hold
17
– – ﹤0.01% 792
2018
Q4 		$2K Buy
+17
New +$1.79K ﹤0.01% 688

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Institutional & Family Asset Management's HAE Position: Q2 2024 in Review

Institutional & Family Asset Management held its Haemonetics (HAE) position steady in Q2 2024 at 9 shares worth $745. The position accounts for ﹤0.01% of the portfolio, ranked #670.

Institutional & Family Asset Management first reported a position in HAE in Q4 2018 and has held it in 12 quarters since. The position peaked at $3K in Q4 2019. 317 funds tracked by Wall St. Rank hold HAE as of Q2 2024.

  • Institutional & Family Asset Management held 9 shares of Haemonetics worth $745 as of Q2 2024.
  • Institutional & Family Asset Management left its Haemonetics share count unchanged in Q2 2024.
  • Haemonetics made up ﹤0.01% of Institutional & Family Asset Management's portfolio in Q2 2024, its #670 holding.
  • Institutional & Family Asset Management first reported a position in Haemonetics in Q4 2018 and has held it in 12 quarters since.
  • Institutional & Family Asset Management's Haemonetics position peaked at $3K in Q4 2019.
  • 317 funds tracked by Wall St. Rank held Haemonetics as of Q2 2024.

Based on Institutional & Family Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.